选择性细胞周期蛋白依赖性激酶抑制剂: 创伤性脑损伤未来临床试验中有希望的候选药物
… More recently, we demonstrated the neuroprotective potential of roscovitine and a related …
5% of the roscovitine dose previously shown to be effective in the same TBI model (Kabadi et al…
5% of the roscovitine dose previously shown to be effective in the same TBI model (Kabadi et al…